Notably, a metabolomic analysis indicted that breast tumor tissues had a higher glutamate‐to-glutamine ratio (GGR) than normal tissues, especially in estrogen receptor (ER) negative tumors and the GGR levels dramatically correlated with ER status and tumor grade (48). This evidence concerns the gene ESR1 and breast neoplasm.